R1 RCM Inc (NYSE:RCM) issued its quarterly earnings results on Tuesday. The company reported ($0.03) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.03), reports. R1 RCM had a negative return on equity of 51.77% and a negative net margin of 6.74%.

Shares of R1 RCM (NYSE RCM) traded up 0.80% during midday trading on Tuesday, hitting $3.80. The company had a trading volume of 256,985 shares. The company’s market capitalization is $388.87 million. R1 RCM has a 12-month low of $2.02 and a 12-month high of $4.37. The company’s 50-day moving average price is $3.58 and its 200 day moving average price is $3.56.

RCM has been the subject of several recent research reports. Zacks Investment Research upgraded R1 RCM from a “hold” rating to a “buy” rating and set a $4.00 price target for the company in a research note on Thursday, July 6th. Robert W. Baird reiterated a “hold” rating and issued a $5.00 price target on shares of R1 RCM in a research note on Tuesday, September 26th.

WARNING: “R1 RCM Inc (RCM) Posts Quarterly Earnings Results, Meets Expectations” was posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this story on another publication, it was illegally copied and republished in violation of U.S. and international copyright and trademark laws. The original version of this story can be viewed at https://theolympiareport.com/2017/10/31/r1-rcm-inc-rcm-posts-quarterly-earnings-results-meets-expectations.html.

About R1 RCM

R1 RCM Inc, formerly Accretive Health, Inc, is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers.

Receive News & Ratings for R1 RCM Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.